We are almost there ...
Plea filed in SC seeking medical panel to look into Covishield risk factors
This development follows AstraZeneca admitting that its COVID-19 vaccine could cause blood clot-related side effects in ‘very rare’ cases.
01 May, 2024•2 min
0
01 May, 2024•2 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Chaos
Chaos
When the US stoops to corporate interests, democracy suffers
The Trump administration’s unprecedented kowtowing to corporate power poses an existential question for democracy worldwide
You may also like
Business
Business schools find themselves at a crossroads as the consulting spell breaks
While consulting remains the most sought-after career choice at top B-schools, the sector itself is experiencing its worst downturn in recent history.
Markets
Why Nifty 50’s profit is the lowest since COVID-19 pandemic
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.
Chaos
Why must you choose the right preschool
Preschool education plays a vital role in developing a child’s social and cognitive skills—and isn’t just about play and fun.
